Does antiemetic ondansetron prevent intra-procedure nausea and vomiting in patients undergoing transcatheter aortic valve replacement with sedation?

Does ondansetron prevent intra-procedure nausea and vomiting in patients undergoing transcatheter aortic valve replacement with conscious sedation? - The effect of ondansetron on intra-procedure nausea and vomiting during transcatheter aortic valve replacement.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056446

Enrollment

100

Registered

2025-01-01

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing transfemoral transcatheter aortic valve replacement with conscious sedation

Exclusion criteria

Exclusion criteria: Patients who are converted to general anesthesia during the procedure or are unconscious

Design outcomes

Primary

Measure	Time frame
The primary endpoint was an incidence of intra-procedure nausea and vomiting during transfemoral transcatheter aortic valve replacement procedures.	—

Countries

Japan

Contacts

Public ContactHiroyuki Kinoshita

Hamamatsu University School of Medicine Departments of Anesthesiology and Intensive Care

hkinoshi@krc.biglobe.ne.jp053-435-2286

Outcome results